Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease. - Wikidata - wikimedia - TriplyDB

Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.

Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.

http://www.wikidata.org/entity/Q35772657

about

Gastroesophageal reflux disease: medical or surgical treatment?Early pharmaceutical evaluation of a crystalline and hygroscopic GABAB receptor agonist.Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.Current trends in the management of gastroesophageal reflux disease: a review.Novel approaches to the pharmacological blockade of gastric acid secretion.Emerging drugs for gastro-oesophageal reflux disease.Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?Developments in the inhibition of gastric acid secretion.Role of potassium in acid secretion An update on the available treatments for non-erosive reflux disease.Gastroesophageal reflux in critically ill children: a review.Review article: from 1906 to 2006--a century of major evolution of understanding of gastro-oesophageal reflux disease.Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers.

P2860

Q33580756-54A831ED-F49D-4EFB-A9FC-DCD11F37F08B Q34173395-631F2AF4-DC23-41E2-9FA3-203402C022C0 Q35049112-41C3A658-AE94-42FE-A8E6-8F2ED04435A4 Q36107247-20CD80F2-5C9F-40BB-9A64-BF5B369F5EEB Q36120771-EC1948CD-7E42-429B-9E3F-170C119A6952 Q36150665-96D20A02-3066-486D-A554-BDFB316FC763 Q36206589-63C8C8C4-09D6-4A8B-A634-0CB4B55CDEFC Q36230670-E321C91A-A28A-4310-9711-E4E62E199BB8 Q36252012-2493D1FA-B686-445C-97D2-9B404F41DBEF Q36349598-1E333A7D-F9E7-4347-86E9-E26C14FB8E91 Q36610419-612A2A1B-6E86-4206-9772-347D9D77A041 Q36632307-A6A9D111-2EF9-4902-8EE4-33288D70F22C Q36916853-3DC9241C-9B53-4038-BB55-2C60D58CA6B3 Q45289833-74462DE0-8D24-4056-A1B3-CA540D6EBF67

P2860

Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.

http://www.wikidata.org/entity/Q35772657

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@ast

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@en

type

label

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@ast

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@en

prefLabel

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@ast

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@en

P1433

Q35772657-416BBB24-1C12-4737-90D1-A614CDC9FB69

P1476

Q35772657-DDF3FEF1-7229-4F50-8487-585C1F3F3806

P2093

Q35772657-DE61C47A-F6B8-4660-AC92-CC70A37E7F3E

P2860

Q35772657-07C880DD-6FDC-4BFC-97E0-FAADAE048C29

Q35772657-0CB35762-18BE-44D3-9676-8F42A1D2D27E

Q35772657-0E9712D5-2715-48C1-ADA3-6A9F85F85C22

Q35772657-0EDA8359-958B-4F5D-9303-6009DD1218D3

Q35772657-17582A2B-ACBA-4721-B255-0F4FA0B59A1A

Q35772657-3662C8EE-7B29-4852-933D-037CC37CD404

Q35772657-433CC0AB-4885-433D-A07E-2AAA4969A020

Q35772657-4B61D6B0-B676-4CA2-A238-B4F52FC88BAB

Q35772657-606F856C-CC6D-4AC4-882C-DD1DD737FCEB

Q35772657-622C959C-58D6-4435-B06B-FEDF6E6C335B

P304

Q35772657-75994E41-7C96-4CA5-93A2-D7D350B26179

P31

Q35772657-D81EC752-9F3A-4954-848C-CCBD326E3423

P356

Q35772657-39B09A09-8D02-44B3-81B0-3F1A0B13F985

P407

Q35772657-F2422DBB-FE56-4D2B-BE54-63D31EA7E6C6

P433

Q35772657-5D8D3D0A-3209-4751-B084-F7E3C87BFE7C

P478

Q35772657-6F22C5D9-F11B-4BC2-9CA1-A388FA008FCE

P577

Q35772657-073F6142-78FA-45B4-A8AD-DF1C07FAEB9B

P5875

Q35772657-3F3DC38C-56B2-458C-A4AC-2AFC1CFD3261

P698

Q35772657-0B5CCF9E-E983-4963-9B64-EE681DF27AA5

P356

J.1365-2036.2004.01957.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Review article: new pharmacolo ...... ro-oesophageal reflux disease.

@en

P2093

Vakil N

http://www.w3.org/2001/XMLSchema#string

P2860

Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors.

Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.

Azomethine prodrugs of (R)-alpha-methylhistamine, a highly potent and selective histamine H3-receptor agonist.

Current trends in the treatment of upper gastrointestinal disease.

Reversible inhibitors of the gastric (H+/K+)-ATPase as both potential therapeutic agents and probes of pump function.

Effect of atropine on proximal gastric motor and sensory function in normal subjects

Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.

Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors

R-alpha-methylhistamine-induced inhibition of gastric acid secretion in pylorus-ligated rats via central histamine H3 receptors.

Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.

P304

1041-1049

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2004.01957.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51415680

http://www.w3.org/2001/XMLSchema#string

P698

15142193

http://www.w3.org/2001/XMLSchema#string